| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30059931 | HIV | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS30059932 | HIV | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS30059933 | HIV | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS30059934 | HIV | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS20058474 | HPV | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS20037924 | HPV | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS20067984 | HPV | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS44019356 | HTLV-1 | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS44006829 | HTLV-1 | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
| TVIS44028343 | HTLV-1 | ENSG00000151834.16 | protein_coding | GABRA2 | No | No | 2555 | E9PBQ7 P47869 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GABRA2 |
|---|---|
| DrugBank ID | DB01496 |
| Drug Name | Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione |
| Target ID | BE0000381 |
| UniProt ID | P47869 |
| Regulation Type | potentiator |
| PubMed IDs | 11264449; 10209232 |
| Citations | Yamakura T, Bertaccini E, Trudell JR, Harris RA: Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol. 2001;41:23-51.@@Mehta AK, Ticku MK: An update on GABAA receptors. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217. |
| Groups | Experimental; Illicit |
| Direct Classification | Trifluoromethylbenzenes |
| SMILES | FC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1 |
| Pathways | |
| PharmGKB | |
| ChEMBL |
